ResultsIQ › Latest results › Novartis India Limited
Novartis India Limited investor meet summary
NSE: NOVARTIND · BSE: 500672
Investor meet of 11 Sep 2026, summarised by AI from the filing.
Novartis India targets at least doubling revenue in four to five years, with near-term cost impact from commercial reset.
Key takeaways
- Revenue trend Company has been flattish in revenue and PAT over the last four years.
- Guidance At least doubling revenue in next four to five years, organically.
- Change New ownership by ChrysCapital with 70.68% stake; new board and management team.
- Risk Transition plan will incur near-term costs and one-time costs, impacting profitability.
Novartis India Limited earnings call, investor presentation and press release summaries
- Other events: Investor meet (11 Sep 2026), Strategy deck (11 Sep 2026)
Figures from the company's filings with NSE and BSE. Not investment advice.